Home

Boxer Capital, LLC

CIK 1465837 · last filed 2023-10-11

Boxer Capital, LLC is a corporate insider who has filed 27 SEC Form 4 insider transactions across 8 companies since 2009. The most recent filing shows the insider sold $11.2M of TNGX on Oct 11, 2023. Across all open-market trades the lifetime net is +$238.2M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $422.2M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$422.24M

Companies

8

Total Filings

27

Lifetime Open-Market Net

$238.19M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
TNGX 13,937,092 $27.97 $389.82M -$11.20M 1 2023-10-11
RAIN Director 1,152,212 $2.06 $2.37M $54.57M 2 2023-05-24
Odonate Therapeutics, Inc. (ODT) Delisted Director 4,207,086 $1.12 $4.71M $133.68M 8 2021-11-24
PMVP 982,708 $1.13 $1.11M $85.50M 1 2020-09-29
iTeos Therapeutics, Inc. (ITOS) Delisted 10%+ Owner 2,943,568 $10.15 $29.88M $108.30M 1 2020-07-29
Mirati Therapeutics, Inc. (MRTX) Delisted 10%+ Owner 1,765,560 $58.70 $103.64M -$122.81M 8 2020-01-14
SLDB 10%+ Owner 3,473,272 $8.33 $28.93M -$4.45M 1 2019-03-28
Pernix Sleep, Inc. (SOMX) Delisted 876,489 — — -$5.40M 2 2009-08-28

Recent Filings

27 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2023-10-11 TNGX Sell (S) −1,125,000 -$11.20M EDGAR
2023-10-10 TNGX Notice (144) −175,000 -$1.99M EDGAR
2023-08-23 iTeos Therapeutics, Inc. (ITOS) Delisted Notice (144) −225,000 -$2.64M EDGAR
2023-05-24 RAIN Sell (S) −3,980,000 -$4.97M EDGAR
2023-05-22 — Notice (144) −495,000 -$4.92M EDGAR
2021-11-24 Odonate Therapeutics, Inc. (ODT) Delisted Sell (S) −1,200,000 -$1.87M EDGAR
2021-04-27 RAIN Mixed +3,525,000 $59.54M EDGAR
2020-12-30 Odonate Therapeutics, Inc. (ODT) Delisted Buy (P) +1,200,000 $20.59M EDGAR
2020-09-30 Odonate Therapeutics, Inc. (ODT) Delisted Buy (P) +645,600 $8.80M EDGAR
2020-09-29 PMVP Mixed +11,645,365 $85.50M EDGAR
Showing 1–10 of 27
Page 1 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.